Case Report: C-reactive protein apheresis in non-ST-elevation ACS—case series from the C-reactive protein apheresis in Acute Myocardial Infarction Registry
C-reactive protein (CRP) apheresis has been introduced in ST-elevation myocardial infarction and cardiogenic shock. Here, we describe a first-in-man application in non-ST-elevation acute coronary syndrome (NSTE-ACS). Seven NSTE-ACS patients with high CRP levels (range 14.2-154 mg/L) were treated with CRP apheresis. Treatment was well-tolerated. Patients were discharged in good clinical condition.
Authors
- Jan Torzewski (ORCID: https://orcid.org/0000-0003-4959-7293)
- Fabrizio Esposito (ORCID: https://orcid.org/0000-0002-5099-9786)
- Ahmed Sheriff (ORCID: https://orcid.org/0000-0001-5074-1198)
- Jiří Fiedler
- Stephan Mattecka (ORCID: https://orcid.org/0009-0000-1149-4075)
- Franz Heigl
Institutions
- Kempten University of Applied Sciences (DE)
- Gemeinschaftskrankenhaus Havelhöhe (DE)
- Pentracor (Germany) (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-08-15
- DOI
- https://doi.org/10.3389/fcvm.2024.1401566
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.80